欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号BE/H/0290/001
药品名称NeisVac-C
活性成分
    • Meningococcal group C oligosaccharide 0.5 ml
剂型Suspension for injection
上市许可持有人Pfizer SA Boulevard de la Plaine, 17 1050 Bruxelles Belgium
参考成员国 - 产品名称Belgium (BE)
Neisvac
互认成员国 - 产品名称
    • Spain (ES)
    • United Kingdom (Northern Ireland) (XI)
      PL 00116/0351 - 0068
    • Germany (DE)
    • Denmark (DK)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
      NeisVac-C Injektionssuspension in einer Fertigspritze
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
      Neis-Vac-C Baxter
    • Lithuania (LT)
      NeisVac-C 0,5 ml injekcinė suspensija užpildytame švirkšte
    • Hungary (HU)
    • Cyprus (CY)
    • Malta (MT)
许可日期2008/04/05
最近更新日期2025/01/20
药物ATC编码
    • J07AH Meningococcal vaccines
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase